期刊文献+

血清胱抑素C和其他肾功能指标评价肾功能损害的差异比较 被引量:10

下载PDF
导出
摘要 目的比较血清胱抑素C(CysC)和其他常用肾功能指标在评价不同程度肾损伤时的差异。方法选择慢性肾损伤患者85例,以Cockcroft-Gau1t方程(C-G方程)计算的肾小球滤过率(GFR)为参考标准,将其分为3组,A组轻度肾损伤35例,B组中度肾损伤34例,C组重度肾损伤或衰竭16例,比较各指标在三组中的差异,并对各指标与GFR的相关性进行分析。结果A组和B组比较,仅CysC有显著性差异;B组和C组比较,各指标均有显著性差异。CysC、BUN、Scr、mAlb与GFR均呈负相关。初步建立了基于CysC估算GFR的公式:GFR=84.7×CysC-1.26。结论 CysC在轻、中、重度肾损伤组中均有显著性差异,而其他常用肾功能指标在中、重度肾损害组有显著性差异。在肾功能早期损害的评价上,CysC要优于其他肾功能指标。
出处 《国际检验医学杂志》 CAS 2014年第14期1953-1954,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献12

  • 1Coresh J,Selvin E, Lesley S, et al. Prevalance of Chronic Kindney Disease in the United States[J]. JAMA, 2007, 298(17) : 2038- 2047.
  • 2张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:369
  • 3Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States; findings from the third National Health and Nutrition Examina tion Survey(1988-1994)[J]. Arch Intern Med,2001,161(9) :1207- 1216.
  • 4Lypez GJM, Sacristdn EB, Micy M, et al. Serum cystatin C and mi- croalbuminuria in the detection of vascular and renal damage in early stages[J]. Nefroiogia,2011,3l(5) .560-566.
  • 5黄晋,刘皓.血清胱抑素C对早期肾功能损伤的诊断意义[J].中国医学创新,2013,10(18):102-104. 被引量:12
  • 6Bevc S, Hojs R, Ekart R, et al. Simple cystatin C formula com- pared to serum creatinine-based formulas for estimation of glo- merular filtration rate in patients with mildly to moderately im- paired kidney function[J]. Kidney Blood Press Res, 2012,35 (6) : 649-654.
  • 7Cockcroft DW, Gault MIA. Predict ion of creatinine clearance from serunl creatinine[J]. Nephron, 1976,16 : 31-41.
  • 8马迎春,左力,王梅,周玉红,张春丽,徐国宾,王海燕.肾小球滤过率评估方程在慢性肾脏病不同分期中的适用性[J].中华内科杂志,2005,44(4):285-289. 被引量:82
  • 9熊子波,高宙,熊祖应,陈丽,侯霜,罗琼.肾小球滤过率评估方法的临床适用性比较[J].罕少疾病杂志,2007,14(3):25-28. 被引量:2
  • 10Larsson A, Maim J,Grubb A, et al. Calculation of glomerular fil- tration rate expressed in mL/min from plasma cystatin C values in mg/L[J]. Stand J Clin Lab Invest,2004,64(1) :25-30.

二级参考文献43

  • 1马迎春,左力,王梅,周玉红,张春丽,徐国宾,王海燕.肾小球滤过率评估方程在慢性肾脏病不同分期中的适用性[J].中华内科杂志,2005,44(4):285-289. 被引量:82
  • 2张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 3全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:702
  • 4Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
  • 5Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
  • 6Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
  • 7Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
  • 8Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
  • 9Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
  • 10Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.

共引文献454

同被引文献112

  • 1胡峰,彭武建,李桂霞,廖娴,韩雪兰,韩璐.联合抗病毒治疗药物对艾滋病患者肾损伤的临床观察[J].世界最新医学信息文摘,2020(3):55-56. 被引量:2
  • 2张荣珍,陈志祥,胡素颖,郑云菊,周明林.3578例高血压中医证型构成临床调查研究[J].中医药临床杂志,2007,19(4):360-364. 被引量:67
  • 3ASRANI SK, O'LEARY JG. Acute- on-chronic fiver failure [J]. Clin Liver Dis, 2014, 18(3) : 561 -574.
  • 4ACHIM C, ZGURAA, ZGURA D, et al. Current therapies in hepatorenal syndrome[ J]. Rom J Intern Med, 2014, 52 (4) : 201 -215.
  • 5SALERNO F, GERBES A, GINES P, et al. Diagnosis, pre- vention and treatment of hepatorenal syndrome in cirrhosis [J]. Postgrad MedJ, 2008, 84(998): 662 -670.
  • 6INAL S, ALTUNTAS A, KIDIR V, et al. Utility of serum creatinine/ cystatin C ratio in diagnosis of postrenal acute kidney injury[J]. J Res Med Sci, 2014, 19(11): 1086-1089.
  • 7CHOLONGITAS E, SHUSANG V, MARELLI L, et al. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements[J]. Aliment Pharmacol Ther, 2007, 26(7) : 969 -978.
  • 8ROSSLE M, GERBES AL. TIPS for the treatment of refracto- ry ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update[J]. Gut, 2010, 59(7): 988 -1000.
  • 9Asrani SK, O'Leary JG. Acute - on - chronic liver failure [ J]. Clin Liver Dis, 2014, 18(3) : 561 -574.
  • 10Achim C, Zgura A, Zgura D, et al. Current therapies in hepatore- ual syndrome[J]. Rom J Intern Med, 2014, 52(4) : 201 -215.

引证文献10

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部